W. Tad Archambault

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

Thomas P. Monath, Richard Nichols, W. Tad Archambault et al. · American Journal of Tropical Medicine and Hygiene · 2002 · 177 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly

Thomas P. Monath, Martín S. Cetron, Karen McCarthy et al. · Human Vaccines · 2005 · 103 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study

Harvey Moldofsky, HERBERT W. HARRIS, W. Tad Archambault et al. · The Journal of Rheumatology · 2011 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.

Lee S. Simon, Hind T. Hatoum, Richard M. Bittman et al. · PubMed · 1996 · 77 citations

Medicine, Pharmacology, Pharmacotherapy +17

Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial

Peter E. Carson, S. William Tam, Jalal K. Ghali et al. · Journal of Cardiac Failure · 2009 · 67 citations

Medicine, Cardiology, Outcomes Research +15